Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis. (May 2016)

• Record Type: Journal Article
• Authors: Garcia-Pelayo, M. Carmen; Kaveh, Daryan A.; Sibley, Laura; Webb, Paul R.; Bull, Naomi C.; Cutting, Simon M.; Hogarth, Philip J.
• Is Part Of: Tuberculosis. Volume 98(2016)
• Page Start: 97
• Page End: 103
• Publication Date: 2016-05
• Subjects: Bovine tuberculosis -- Vaccine -- Spores -- BCG -- Heterologous prime-boost; 616.995
• DOI: 10.1016/j.tube.2016.03.004
• Languages: English
• ISSNs: 1472-9792

Abstract

Summary: Tuberculosis (TB) remains a global pandemic, in both animals and man, and novel vaccines are urgently required. Heterologous prime-boost of BCG represents a promising strategy for improved TB vaccines, with respiratory delivery the most efficacious to date. Such an approach may be an ideal vaccination strategy against bovine TB (bTB), but respiratory vaccination presents a technical challenge in cattle. Inert bacterial spores represent an attractive vaccine vehicle. Therefore we evaluated whether parenterally administered spores are efficacious when used as a BCG boost in a murine model of immunity against Mycobacterium bovis . Here we report the use of heat-killed, TB10.4 adsorbed, Bacillus subtilis spores delivered via subcutaneous injection to boost immunity primed by BCG. We demonstrate that this approach improves the immunogenicity of BCG. Interestingly, this associated with substantial boosting of IL-17 responses; considered to be important in protective immunity against TB. These data demonstrate that parenteral delivery of spores represents a promising vaccine vehicle for boosting BCG, and identifies potential for optimisation for use as a vaccine for bovine TB.